MACROH2A2 and breast cancer: Scatter plots (Figure 4B) demonstrated that SRGN (p < 0.0001), FLI1 (p < 0.0001), and MACROH2A2 (p < 0.0001) were statistically significant as individual biomarkers in distinguishing BC patients from HC donors.